Monthly Archive: August 2014
Reporting on 100 recent cases of fetal surgery for spina bifida, specialists from The Children’s Hospital of Philadelphia achieved results similar to those in a landmark clinical trial that established a new standard of care for prenatal repair of this birth defect.
Permanent link to this article: http://www.research.chop.edu/blog/report-100-prenatal-surgeries-spina-bifida-support-new-standard-care/
Any opportunity to get a research project off the ground is greatly appreciated, especially by the two Children’s Hospital of Philadelphia physicians who recently received 2014 Pilot Grant Awards from the Center for Pediatric Clinical Effectiveness (CPCE).
Permanent link to this article: http://www.research.chop.edu/blog/investigators-excited-receive-cpce-pilot-grant-awards/
The Children’s Hospital of Philadelphia’s Lacramioara Ivanciu, PhD, was one of five investigators who recently received funding through the Bayer Hemophilia Awards Program (BHAP).
Permanent link to this article: http://www.research.chop.edu/blog/award-will-support-novel-hemophilia-therapy-investigation/
Researchers from the Sleep Center at The Children’s Hospital of Philadelphia are set to launch the “Steroids for Pediatric Research in Kids (SPARK)” trial in September that will investigate the use of nasal corticosteroids as a possible treatment for OSAS.
Permanent link to this article: http://www.research.chop.edu/blog/new-study-focuses-nasal-steroids-osa-treatment/
Many of the major milestones in understanding eosinophilic esophagitis (EoE), a food allergy that affects the esophagus, began in research laboratories at The Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania.
Permanent link to this article: http://www.research.chop.edu/blog/investigating-new-approach-eosinophilic-esophagitis/
Investigators at The Children’s Hospital of Philadelphia are exploring a new gene therapy approach that aims to reactivate the production of fetal hemoglobin as a potential intervention for patients with sickle cell disease.
Permanent link to this article: http://www.research.chop.edu/blog/forced-looping-viable-strategy-reverse-globin-switch/
Clinicians in neonatal intensive care units across the country are uncertain about when to administer rotavirus vaccination to infants whose medical conditions require prolonged hospital stays.
Permanent link to this article: http://www.research.chop.edu/blog/investigators-explore-safety-rotavirus-vaccine-nicu/
A recent event at the Center for Injury Research and Prevention (CIRP) celebrated the wide-ranging accomplishments of a number of students who have been working with CIRP staff and investigators.
Permanent link to this article: http://www.research.chop.edu/blog/celebrating-student-contributions-injury-research/
CHOP has long investigated biodegradable nanoparticles for medical use. With diameters ranging from a few tens to a few hundreds of nanometers, these particles are 10 to 1000 times smaller than red blood cells.
Permanent link to this article: http://www.research.chop.edu/blog/biodegradable-nanoparticles-may-hold-therapeutic-use/
As daily temperatures increase, so does the number of patients seeking treatment for kidney stones.
Permanent link to this article: http://www.research.chop.edu/blog/climate-change-mean-kidney-stones/